SELLAS Life Sciences prices $150 million stock offering at $13 per share
SELLAS Life Sciences signed a placement agreement with J.P. Morgan Securities and TD Securities for a public offering of 11,538,462 common shares at $13 per share. The placement agents also received a 30-day option to buy up to 1,730,769 additional shares; if fully exercised, the company expects net proceeds of about $161.8 million after deducting discounts, commissions and estimated expenses. The offering is expected to close on or around November 20, 2026.
In 30 seconds
- Public offering of 11,538,462 common shares at $13 each
- J.P. Morgan Securities and TD Securities act as placement agents
- 30-day option for up to 1,730,769 additional shares
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.